Radionuclide studies in surgical oncology.
Over the last forty years radionuclides have come to play a useful role in diagnosis and treatment of tumours. Radionuclide scintigraphy provides information on morphology and function of tumours; functional studies have become more relevant with advances in instrumentation such as digitised gamma-cameras, single-photon emission tomography (SPECT), position-emission tomography (PET), and with advances in radiopharmaceuticals. A significant contribution in recent years has been the use of radiolabelled antibodies in immunoscintigraphy and immunotherapy; an increasing role is envisaged also for the use of tests for tumour markers in vitro.
Sundram
F X
FX
Department of Nuclear Medicine, Singapore General Hospital.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001842:Bone and Bones / Q000000981:diagnostic imaging; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008099:Liver / Q000000981:diagnostic imaging; D008495:Medical Oncology; D011877:Radionuclide Imaging
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D007457:Iodine Radioisotopes